Search Within

Gynecology Disease Management Team

Formats
  1. Journal Article (2473)
  2. Meeting Abstract (2112)
  3. Book Section (226)
  4. Review (135)
  5. Editorial (88)
  6. Guidelines (39)
  7. Correspondence (19)
  8. Conference Paper (16)
  9. Miscellaneous (13)
  10. Research Letter (12)
  11. Book Whole (11)
Groups
  1. Surgery (2362)
  2. Department of Medicine (2268)
  3. Solid Tumor Oncology Division (2217)
  4. GDMT, Surgery (1974)
  5. GDMT, Medicine (1910)
  6. Gynecologic Medicine Service (1877)

More Groups

People
  1. Nadeem Abu-Rustum (902)
  2. Robert Soslow (797)
  3. Dennis Chi (716)
  4. Britta Weigelt (646)
  5. Carol Aghajanian (615)
  6. Mario Leitao (582)

More People

Years
  1. 2025 (161)
  2. 2024 (308)
  3. 2023 (332)
  4. 2022 (361)
  5. 2021 (308)
  6. 2020 (356)

More Years

Publications
  1. Gynecologic Oncology (950)
  2. Journal of Clinical Oncology (543)
  3. Modern Pathology (354)
  4. International Journal of Gynecological Cancer (321)
  5. Laboratory Investigation (311)
  6. International Journal of Radiation Oncology, Biology, Physics (223)

More Publications

Publishers
  1. Elsevier B.V. (1001)
  2. American Society of Clinical Oncology (598)
  3. Lippincott Williams & Wilkins (584)
  4. Elsevier Inc. (481)
  5. Nature Publishing Group (424)
  6. Nature Research (356)

More Publishers

Results (5144)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Maintenance and assessment of skills and knowledge over the career continuum
    Book Section

    Wallner, P. E.; Kachnic, L. A.; Alektiar, K. M.
    In Chandra, R. A.; Vapiwala, N.; Thomas, C. R. Jr (Eds.) Career Development in Academic Radiation Oncology (2021)

    Fulltext@MSK | Save
  • Diseases of the peritoneum
    Book Section

    Soslow, R. A.
    In Nucci, M. R.; Parra-Herran, C. (Eds.) Gynecologic Patholoy. 2nd ed (2021)

    Fulltext@MSK | Save
  • Zanubrutinib, obinutuzumab, and venetoclax in chronic lymphocytic leukemia: Early MRD kinetics define a high-risk patient cohort with delayed bone marrow undetectable MRD and earlier post-treatment MRD recurrence
    Meeting Abstract

    Soumerai, J. D.; Mato, A. R.; Dogan, A.; Seshan, V.; Joffe, E.; Flaherty, K.; Carter, J.; Hochberg, E. P.; Barnes, J. A.; Hamilton, A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Lenvatinib and pembrolizumab in advanced endometrial carcinoma (EC): Long-term efficacy and safety update from a phase 1b/2 study
    Meeting Abstract

    Makker, V.; Aghajanian, C.; Cohn, A.; Romeo, M.; Bratos, R.; Brose, M.; Messing, M.; Dutta, L.; Dutcus, C.; Huang, J.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • T cell intrinsic DNA damage and repair response as a novel marker associated with clinical response to PD-1 blockade
    Meeting Abstract

    Muroyama, Y.; Manne, S.; Greenplate, A.; Mathew, D.; Oldridge, D.; Chilukuri, L.; Xu, C.; Herati, R.; Huang, A.; Zamarin, D.; more...
    Journal for ImmunoTherapy of Cancer (2021)

    Fulltext@MSK | Save
  • Molecular analysis of primary endometrial cancer and matched lung metastases
    Meeting Abstract

    Gordhandas, S.; Da Cruz Paula, A.; Kertowidjojo, E.; Dessources, K.; Maroldi, A.; Da Silva, E.; Derakhshan, F.; Abu-Rustum, N.; Weigelt, B.
    International Journal of Gynecological Cancer (2021)

    Fulltext@MSK | Save
  • Tisotumab vedotin (TV) + bevacizumab or pembrolizumab or carboplatin in recurrent/metastatic cervical cancer (r/mCC): Phase 1b/2 ENGOT-cx8/GOG-3024/ innovaTV 205 study dose-escalation results
    Meeting Abstract

    Monk, B.; Van Gorp, T.; Lorusso, D.; O'Cearbhaill, R. E.; Westermann, A.; Banerjee, S.; Collins, D.; Klat, J.; Madsen, K.; Baurain, J. F.; more...
    International Journal of Gynecological Cancer (2021)

    Fulltext@MSK | Save
  • Comprehensive genomic profiling of low-grade serous cancers and associated clinical outcomes
    Meeting Abstract

    Manning-Geist, B.; Gordhandas, S.; Da Cruz Paula, A.; Weigelt, B.; Liu, Y.; Chui, H.; Grisham, R.
    International Journal of Gynecological Cancer (2021)

    Fulltext@MSK | Save
  • Clinical and molecular characteristics of ARIEL3 patients who derived exceptional benefit from rucaparib maintenance treatment for high-grade ovarian cancer (HGOC)
    Meeting Abstract

    Coleman, R. L.; Oza, A.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J.; Clamp, A.; Scambia, G.; more...
    International Journal of Gynecological Cancer (2021)

    Fulltext@MSK | Save
  • Randomized phase 3 study of lenvatinib plus pembrolizumab for advanced endometrial cancer (aEC): Subgroup analysis of patients with DNA mismatch repair deficient (DMMR) tumors
    Meeting Abstract

    Makker, V.; Colombo, N.; Casado Herráez, A.; Santin, A.; Colomba, E.; Miller, D.; Fujiwara, K.; Pignata, S.; Banerjee, S.; Monk, B.; more...
    International Journal of Gynecological Cancer (2021)

    Fulltext@MSK | Save